http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 18 Jun 2026 04:49:29 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Intl+Ratings/Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+PT+Lowered+to+CHF7.50+at+Deutsche+Bank/26661987.html Deutsche Bank analyst Tristan Lamotte lowered the price target on Clariant AG (CLN:SW) (OTC: CLZNY) to CHF7.50 (from CHF7.70) while maintaining a Hold rating. http://www.streetinsider.com/Intl+Ratings/Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+PT+Lowered+to+CHF7.50+at+Deutsche+Bank/26661987.html Thu, 18 Jun 2026 04:49:29 -0400 CLZNY http://www.streetinsider.com/Analyst+PT+Change/Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+PT+Lowered+to+CHF7.50+at+Deutsche+Bank/26661987.html Deutsche Bank analyst Tristan Lamotte lowered the price target on Clariant AG (CLN:SW) (OTC: CLZNY) to CHF7.50 (from CHF7.70) while maintaining a Hold rating. http://www.streetinsider.com/Analyst+PT+Change/Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+PT+Lowered+to+CHF7.50+at+Deutsche+Bank/26661987.html Thu, 18 Jun 2026 04:49:29 -0400 CLZNY http://www.streetinsider.com/Intl+Ratings/Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+PT+Lowered+to+CHF7.50+at+Deutsche+Bank/26661987.html Deutsche Bank analyst Tristan Lamotte lowered the price target on Clariant AG (CLN:SW) (OTC: CLZNY) to CHF7.50 (from CHF7.70) while maintaining a Hold rating. http://www.streetinsider.com/Intl+Ratings/Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+PT+Lowered+to+CHF7.50+at+Deutsche+Bank/26661987.html Thu, 18 Jun 2026 04:49:29 -0400 CLZNY http://www.streetinsider.com/Analyst+PT+Change/Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+PT+Lowered+to+CHF7.50+at+Deutsche+Bank/26661987.html Deutsche Bank analyst Tristan Lamotte lowered the price target on Clariant AG (CLN:SW) (OTC: CLZNY) to CHF7.50 (from CHF7.70) while maintaining a Hold rating. http://www.streetinsider.com/Analyst+PT+Change/Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+PT+Lowered+to+CHF7.50+at+Deutsche+Bank/26661987.html Thu, 18 Jun 2026 04:49:29 -0400 CLZNY http://www.streetinsider.com/Analyst+PT+Change/Goldman+Sachs+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Neutral/26613296.html <p>Goldman Sachs analyst Georgina Fraser upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Sell to Neutral with a price target of CHF8.50 (from CHF7.50).</p><p>The analyst comments: “We upgrade Clariant to Neutral (from Sell) as the stock screens as relatively more exposed to late-cycle dynamics than diversified peers and benefits from demonstrated pricing power in Care Chemicals. With 16% upside to our new PT, the risk-reward is modest, as we see limited catalysts against a backdrop of FMs and ongoing litigation uncertainty, and struggle to identify a path to material re-rating.</p><p>Given the cyclical slowdown now underway, we think Clariant is better positioned http://www.streetinsider.com/Analyst+PT+Change/Goldman+Sachs+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Neutral/26613296.html Mon, 08 Jun 2026 02:52:05 -0400 CLZNY http://www.streetinsider.com/Intl+Ratings/Goldman+Sachs+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Neutral/26613296.html <p>Goldman Sachs analyst Georgina Fraser upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Sell to Neutral with a price target of CHF8.50 (from CHF7.50).</p><p>The analyst comments: “We upgrade Clariant to Neutral (from Sell) as the stock screens as relatively more exposed to late-cycle dynamics than diversified peers and benefits from demonstrated pricing power in Care Chemicals. With 16% upside to our new PT, the risk-reward is modest, as we see limited catalysts against a backdrop of FMs and ongoing litigation uncertainty, and struggle to identify a path to material re-rating.</p><p>Given the cyclical slowdown now underway, we think Clariant is better positioned http://www.streetinsider.com/Intl+Ratings/Goldman+Sachs+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Neutral/26613296.html Mon, 08 Jun 2026 02:52:05 -0400 CLZNY http://www.streetinsider.com/Upgrades/Goldman+Sachs+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Neutral/26613296.html <p>Goldman Sachs analyst Georgina Fraser upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Sell to Neutral with a price target of CHF8.50 (from CHF7.50).</p><p>The analyst comments: “We upgrade Clariant to Neutral (from Sell) as the stock screens as relatively more exposed to late-cycle dynamics than diversified peers and benefits from demonstrated pricing power in Care Chemicals. With 16% upside to our new PT, the risk-reward is modest, as we see limited catalysts against a backdrop of FMs and ongoing litigation uncertainty, and struggle to identify a path to material re-rating.</p><p>Given the cyclical slowdown now underway, we think Clariant is better positioned http://www.streetinsider.com/Upgrades/Goldman+Sachs+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Neutral/26613296.html Mon, 08 Jun 2026 02:52:05 -0400 CLZNY http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Neutral/26613296.html <p>Goldman Sachs analyst Georgina Fraser upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Sell to Neutral with a price target of CHF8.50 (from CHF7.50).</p><p>The analyst comments: “We upgrade Clariant to Neutral (from Sell) as the stock screens as relatively more exposed to late-cycle dynamics than diversified peers and benefits from demonstrated pricing power in Care Chemicals. With 16% upside to our new PT, the risk-reward is modest, as we see limited catalysts against a backdrop of FMs and ongoing litigation uncertainty, and struggle to identify a path to material re-rating.</p><p>Given the cyclical slowdown now underway, we think Clariant is better positioned http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Neutral/26613296.html Mon, 08 Jun 2026 02:52:05 -0400 CLZNY http://www.streetinsider.com/Analyst+PT+Change/Goldman+Sachs+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Neutral/26613296.html <p>Goldman Sachs analyst Georgina Fraser upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Sell to Neutral with a price target of CHF8.50 (from CHF7.50).</p><p>The analyst comments: “We upgrade Clariant to Neutral (from Sell) as the stock screens as relatively more exposed to late-cycle dynamics than diversified peers and benefits from demonstrated pricing power in Care Chemicals. With 16% upside to our new PT, the risk-reward is modest, as we see limited catalysts against a backdrop of FMs and ongoing litigation uncertainty, and struggle to identify a path to material re-rating.</p><p>Given the cyclical slowdown now underway, we think Clariant is better positioned http://www.streetinsider.com/Analyst+PT+Change/Goldman+Sachs+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Neutral/26613296.html Mon, 08 Jun 2026 02:52:05 -0400 CLZNY http://www.streetinsider.com/Intl+Ratings/Goldman+Sachs+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Neutral/26613296.html <p>Goldman Sachs analyst Georgina Fraser upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Sell to Neutral with a price target of CHF8.50 (from CHF7.50).</p><p>The analyst comments: “We upgrade Clariant to Neutral (from Sell) as the stock screens as relatively more exposed to late-cycle dynamics than diversified peers and benefits from demonstrated pricing power in Care Chemicals. With 16% upside to our new PT, the risk-reward is modest, as we see limited catalysts against a backdrop of FMs and ongoing litigation uncertainty, and struggle to identify a path to material re-rating.</p><p>Given the cyclical slowdown now underway, we think Clariant is better positioned http://www.streetinsider.com/Intl+Ratings/Goldman+Sachs+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Neutral/26613296.html Mon, 08 Jun 2026 02:52:05 -0400 CLZNY http://www.streetinsider.com/Upgrades/Goldman+Sachs+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Neutral/26613296.html <p>Goldman Sachs analyst Georgina Fraser upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Sell to Neutral with a price target of CHF8.50 (from CHF7.50).</p><p>The analyst comments: “We upgrade Clariant to Neutral (from Sell) as the stock screens as relatively more exposed to late-cycle dynamics than diversified peers and benefits from demonstrated pricing power in Care Chemicals. With 16% upside to our new PT, the risk-reward is modest, as we see limited catalysts against a backdrop of FMs and ongoing litigation uncertainty, and struggle to identify a path to material re-rating.</p><p>Given the cyclical slowdown now underway, we think Clariant is better positioned http://www.streetinsider.com/Upgrades/Goldman+Sachs+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Neutral/26613296.html Mon, 08 Jun 2026 02:52:05 -0400 CLZNY http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Neutral/26613296.html <p>Goldman Sachs analyst Georgina Fraser upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Sell to Neutral with a price target of CHF8.50 (from CHF7.50).</p><p>The analyst comments: “We upgrade Clariant to Neutral (from Sell) as the stock screens as relatively more exposed to late-cycle dynamics than diversified peers and benefits from demonstrated pricing power in Care Chemicals. With 16% upside to our new PT, the risk-reward is modest, as we see limited catalysts against a backdrop of FMs and ongoing litigation uncertainty, and struggle to identify a path to material re-rating.</p><p>Given the cyclical slowdown now underway, we think Clariant is better positioned http://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Neutral/26613296.html Mon, 08 Jun 2026 02:52:05 -0400 CLZNY http://www.streetinsider.com/Intl+Ratings/Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+PT+Lowered+to+CHF7.50+at+Citi/26607666.html Citi analyst Ranulf Orr lowered the price target on Clariant AG (CLN:SW) (OTC: CLZNY) to CHF7.50 (from CHF7.80) while maintaining a Neutral rating. http://www.streetinsider.com/Intl+Ratings/Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+PT+Lowered+to+CHF7.50+at+Citi/26607666.html Fri, 05 Jun 2026 04:24:12 -0400 CLZNY http://www.streetinsider.com/Analyst+PT+Change/Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+PT+Lowered+to+CHF7.50+at+Citi/26607666.html Citi analyst Ranulf Orr lowered the price target on Clariant AG (CLN:SW) (OTC: CLZNY) to CHF7.50 (from CHF7.80) while maintaining a Neutral rating. http://www.streetinsider.com/Analyst+PT+Change/Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+PT+Lowered+to+CHF7.50+at+Citi/26607666.html Fri, 05 Jun 2026 04:24:12 -0400 CLZNY http://www.streetinsider.com/Intl+Ratings/Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+PT+Lowered+to+CHF7.50+at+Citi/26607666.html Citi analyst Ranulf Orr lowered the price target on Clariant AG (CLN:SW) (OTC: CLZNY) to CHF7.50 (from CHF7.80) while maintaining a Neutral rating. http://www.streetinsider.com/Intl+Ratings/Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+PT+Lowered+to+CHF7.50+at+Citi/26607666.html Fri, 05 Jun 2026 04:24:12 -0400 CLZNY http://www.streetinsider.com/Analyst+PT+Change/Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+PT+Lowered+to+CHF7.50+at+Citi/26607666.html Citi analyst Ranulf Orr lowered the price target on Clariant AG (CLN:SW) (OTC: CLZNY) to CHF7.50 (from CHF7.80) while maintaining a Neutral rating. http://www.streetinsider.com/Analyst+PT+Change/Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+PT+Lowered+to+CHF7.50+at+Citi/26607666.html Fri, 05 Jun 2026 04:24:12 -0400 CLZNY http://www.streetinsider.com/Analyst+PT+Change/JPMorgan+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Overweight/26537750.html <p>JPMorgan analyst Chetan Udeshi upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Neutral to Overweight with a price target of CHF9.30 (from CHF9.50).</p><p>The analyst comments: “We have cut our FY26/27E adj EBITDA, primarily to reflect the demand headwinds from the Middle East conflict in its chemical catalyst business, and to a smaller extent from higher than previously expected FX headwinds. Our FY26/27E adj EBITDA forecasts of CHF 635m/CHF 698m are 6%/4% below Vara consensus. We upgrade the stock to OW from N -while it has screened as a relative loser from the ME conflict, we see the current discounted valuation as http://www.streetinsider.com/Analyst+PT+Change/JPMorgan+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Overweight/26537750.html Fri, 22 May 2026 02:49:18 -0400 CLZNY http://www.streetinsider.com/Intl+Ratings/JPMorgan+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Overweight/26537750.html <p>JPMorgan analyst Chetan Udeshi upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Neutral to Overweight with a price target of CHF9.30 (from CHF9.50).</p><p>The analyst comments: “We have cut our FY26/27E adj EBITDA, primarily to reflect the demand headwinds from the Middle East conflict in its chemical catalyst business, and to a smaller extent from higher than previously expected FX headwinds. Our FY26/27E adj EBITDA forecasts of CHF 635m/CHF 698m are 6%/4% below Vara consensus. We upgrade the stock to OW from N -while it has screened as a relative loser from the ME conflict, we see the current discounted valuation as http://www.streetinsider.com/Intl+Ratings/JPMorgan+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Overweight/26537750.html Fri, 22 May 2026 02:49:18 -0400 CLZNY http://www.streetinsider.com/Upgrades/JPMorgan+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Overweight/26537750.html <p>JPMorgan analyst Chetan Udeshi upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Neutral to Overweight with a price target of CHF9.30 (from CHF9.50).</p><p>The analyst comments: “We have cut our FY26/27E adj EBITDA, primarily to reflect the demand headwinds from the Middle East conflict in its chemical catalyst business, and to a smaller extent from higher than previously expected FX headwinds. Our FY26/27E adj EBITDA forecasts of CHF 635m/CHF 698m are 6%/4% below Vara consensus. We upgrade the stock to OW from N -while it has screened as a relative loser from the ME conflict, we see the current discounted valuation as http://www.streetinsider.com/Upgrades/JPMorgan+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Overweight/26537750.html Fri, 22 May 2026 02:49:18 -0400 CLZNY http://www.streetinsider.com/Analyst+Comments/JPMorgan+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Overweight/26537750.html <p>JPMorgan analyst Chetan Udeshi upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Neutral to Overweight with a price target of CHF9.30 (from CHF9.50).</p><p>The analyst comments: “We have cut our FY26/27E adj EBITDA, primarily to reflect the demand headwinds from the Middle East conflict in its chemical catalyst business, and to a smaller extent from higher than previously expected FX headwinds. Our FY26/27E adj EBITDA forecasts of CHF 635m/CHF 698m are 6%/4% below Vara consensus. We upgrade the stock to OW from N -while it has screened as a relative loser from the ME conflict, we see the current discounted valuation as http://www.streetinsider.com/Analyst+Comments/JPMorgan+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Overweight/26537750.html Fri, 22 May 2026 02:49:18 -0400 CLZNY http://www.streetinsider.com/Analyst+PT+Change/JPMorgan+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Overweight/26537750.html <p>JPMorgan analyst Chetan Udeshi upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Neutral to Overweight with a price target of CHF9.30 (from CHF9.50).</p><p>The analyst comments: “We have cut our FY26/27E adj EBITDA, primarily to reflect the demand headwinds from the Middle East conflict in its chemical catalyst business, and to a smaller extent from higher than previously expected FX headwinds. Our FY26/27E adj EBITDA forecasts of CHF 635m/CHF 698m are 6%/4% below Vara consensus. We upgrade the stock to OW from N -while it has screened as a relative loser from the ME conflict, we see the current discounted valuation as http://www.streetinsider.com/Analyst+PT+Change/JPMorgan+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Overweight/26537750.html Fri, 22 May 2026 02:49:18 -0400 CLZNY http://www.streetinsider.com/Intl+Ratings/JPMorgan+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Overweight/26537750.html <p>JPMorgan analyst Chetan Udeshi upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Neutral to Overweight with a price target of CHF9.30 (from CHF9.50).</p><p>The analyst comments: “We have cut our FY26/27E adj EBITDA, primarily to reflect the demand headwinds from the Middle East conflict in its chemical catalyst business, and to a smaller extent from higher than previously expected FX headwinds. Our FY26/27E adj EBITDA forecasts of CHF 635m/CHF 698m are 6%/4% below Vara consensus. We upgrade the stock to OW from N -while it has screened as a relative loser from the ME conflict, we see the current discounted valuation as http://www.streetinsider.com/Intl+Ratings/JPMorgan+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Overweight/26537750.html Fri, 22 May 2026 02:49:18 -0400 CLZNY http://www.streetinsider.com/Upgrades/JPMorgan+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Overweight/26537750.html <p>JPMorgan analyst Chetan Udeshi upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Neutral to Overweight with a price target of CHF9.30 (from CHF9.50).</p><p>The analyst comments: “We have cut our FY26/27E adj EBITDA, primarily to reflect the demand headwinds from the Middle East conflict in its chemical catalyst business, and to a smaller extent from higher than previously expected FX headwinds. Our FY26/27E adj EBITDA forecasts of CHF 635m/CHF 698m are 6%/4% below Vara consensus. We upgrade the stock to OW from N -while it has screened as a relative loser from the ME conflict, we see the current discounted valuation as http://www.streetinsider.com/Upgrades/JPMorgan+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Overweight/26537750.html Fri, 22 May 2026 02:49:18 -0400 CLZNY http://www.streetinsider.com/Analyst+Comments/JPMorgan+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Overweight/26537750.html <p>JPMorgan analyst Chetan Udeshi upgraded Clariant AG (CLN:SW) (OTC: CLZNY) from Neutral to Overweight with a price target of CHF9.30 (from CHF9.50).</p><p>The analyst comments: “We have cut our FY26/27E adj EBITDA, primarily to reflect the demand headwinds from the Middle East conflict in its chemical catalyst business, and to a smaller extent from higher than previously expected FX headwinds. Our FY26/27E adj EBITDA forecasts of CHF 635m/CHF 698m are 6%/4% below Vara consensus. We upgrade the stock to OW from N -while it has screened as a relative loser from the ME conflict, we see the current discounted valuation as http://www.streetinsider.com/Analyst+Comments/JPMorgan+Upgrades+Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+to+Overweight/26537750.html Fri, 22 May 2026 02:49:18 -0400 CLZNY http://www.streetinsider.com/Analyst+PT+Change/Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+PT+Raised+to+CHF6+at+Jefferies/26523650.html <p>Jefferies analyst Marcus Dunford-Castro raised the price target on Clariant AG (CLN:SW) (OTC: CLZNY) to CHF6.00 (from CHF5.70) while maintaining a Underperform rating.</p><p>The analyst comments: “We make average 2% EBITDA downgrades, and reiterate our UNDERPERFORM rating, but increase our target price to CHF 6/share (SOTP multiples). Near-term earnings risk remains elevated as Middle East disruption delays catalyst refill orders and higher energy and feedstock costs raise the risk of demand destruction into H2, partly offset by the relative defensiveness of Care Chemicals despite ongoing HPC weakness. Sabic’s inactive stake and a sizeable ethylene litigation overhang continuing to weigh on valuation.”</p> http://www.streetinsider.com/Analyst+PT+Change/Clariant+AG+%28CLN%3ASW%29+%28CLZNY%29+PT+Raised+to+CHF6+at+Jefferies/26523650.html Wed, 20 May 2026 02:07:00 -0400 CLZNY